Skip to content
Valcare Medical Logo Valcare Medical Logo
  • MITRAL REPAIR
  • ABOUT
  • NEWS & PRESS
  • CONTACT
  • SOCIAL MEDIA
  • MITRAL REPAIR
  • ABOUT
  • NEWS & PRESS
  • CONTACT
  • SOCIAL MEDIA

Paul Sorajja, M.D. discusses the First-in-America Implantation of AMEND Annuloplasty Ring in Mitral Regurgitation

Listen to Dr. Paul Sorajja, Interventional Cardiologist at Banner University Medical Center Phoenix, describe the first implantation of the AMEND annuloplasty ring via a novel trans-septal system designed to help a leaky mitral valve. Video here: New catheter procedure treats leaky heart valves – Arizona PBS

For additional news coverage:

Medical breakthrough helps patients avoid open heart surgery – Fox 10 Phoenix

Phoenix hospital performs groundbreaking heart procedure – KTAR.com

First case of transcatheter mitral annuloplasty performed in AMEND EFS trial – Cardiovascular News

Banner Health performs 1st US mitral valve repair implant – Becker’s Cardiology

Banner Health doctor pioneer in heart valve repair – Daily Independent

First-in-America Implantation of AMEND Annuloplasty Ring in Mitral Regurgitation, With Paul Sorajja, MD | HCPLive

Samantha Talpir2026-03-02T17:26:06+00:00March 2nd, 2026|

Related Posts

How AMEND™ TMVr Annuloplasty System Is Re-engineering Mitral Valve Repair

March 1st, 2026

Valcare Medical Announces First U.S. Transseptal AMEND™ Implant in Early Feasibility Study

February 14th, 2026

Valcare Medical Receives FDA Approval to Initiate Early Feasibility Study for its Novel AMEND™ Trans-Septal System

March 13th, 2025
  • MITRAL REPAIR
  • ABOUT
  • NEWS & PRESS
  • CONTACT
  • SOCIAL MEDIA
The AMEND device is an investigational device and limited to investigational use only. The product is not available for sale or commercial distribution.

Copyright Valcare Medical | All Rights Reserved
Page load link
Go to Top